CME:Unlocking the Door to Asthma Control: Key Factors for Therapy Selection and Medication Management

Intended Audience: Physicians, Pharmacists, Nurses, and Case Managers

Frequent asthma flare-ups lock patients out of their own lives by preventing them from fully participating in work/school, getting restful sleep, and engaging in social activities. In this CE accredited program, leading experts in asthma and managed care pharmacy will provide you with the keys to asthma control. Hear the latest evidence from recent conferences while discovering how novel therapies can tame and prevent flare-ups, reduce the impact of asthma-related comorbidities, and avoid the need for costly hospitalizations. Why leave those with severe asthma on the outside of life looking in when you can open the door?

Physicians completing this program will earn AMA PRA Category 1 Credit™ classified as Enduring material.

Pharmacists completing this program will earn Home Study credit in Disease State Mgmt/Drug therapy (H01).

 

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma RT @Aller_MD: Which factors should be considered before escalating treatments in children with severe therapy-resistant #asthma? https://t.…
9hreplyretweetfavorite
Interasma RT @Aller_MD: Analgesics in pregnancy do not seem to cause offspring #asthma https://t.co/pcwbWUNheb
9hreplyretweetfavorite
Interasma RT @Aller_MD: The latest Allergists on Social Media! https://t.co/G1CYpYKwAy
9hreplyretweetfavorite
Interasma RT @Aller_MD: Mother's diet during pregnancy can impact lung-specific genes of her offspring https://t.co/cOD1iWDLx5
9hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma